Figure 4 3.4.5 AEs A total of 21 studies encompassing 23,548 subjects reported AEs in 19,282 subjects across 19 interventions: bexagliflozin, canagliflozin, cotadutide, dapagliflozin, dapagliflozin + exenatide, dapagliflozin + saxagliptin, empagliflozin, ertugliflozin, exenatide, linagliptin, liraglutide, luseogliflozin, omarigliptin, placebo, saxagliptin, semaglutide, sotagliflozin, trelagliptin, and vildagliptin
Ileus (Intestinal Obstruction) In rare cases, ileus, where intestinal movement stops, can occur
Enhanced Detoxification and Immune Support Glutathione is well-known for its detoxifying properties, but when administered through IV therapy, it can take these benefits to the next level
This ailment, known as otalgia, causes symptoms that might linger for a brief time or be ongoing
A GLP-1 can support weight reduction, but the rate and magnitude of loss have to be sustainable and compatible with PT demands and fitness testing schedules